Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D2/D3 Receptor Bitopic Ligands-Reference-Cited by-同舟云学术

Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D2/D3 Receptor Bitopic Ligands

Published:2021-10-12 Issue:20 Volume:64 Page:15313-15333
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Shaik Anver Basha¹^ORCID,Boateng Comfort A.¹^ORCID,Battiti Francisco O.¹,Bonifazi Alessandro¹^ORCID,Cao Jianjing¹,Chen Li²,Chitsazi Rezvan²,Ravi Saiprasad²,Lee Kuo Hao²,Shi Lei²,Newman Amy Hauck¹^ORCID

Affiliation:

1. Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse − Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United States

2. Computational Chemistry and Molecular Biophysics Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse − Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United States

Funder

National Institute on Drug Abuse-Intramural Research Program

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.1c01353

Reference54 articles.

1. Update 1 of: Recent Progress in Development of Dopamine Receptor Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders

2. Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

3. The Physiology, Signaling, and Pharmacology of Dopamine Receptors